LTS develops and manufactures transdermal and oral drug patches for a variety of uses. Here you will find articles with a lot of information.
Rheumatoid arthritis and transdermal application
Microneedles (MAP) are the future technology for LTS and also an appealing alternative cure to the therapy of Rheumatoid arthritis, the most common chronic inflammatory joints disease.